Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for Upper Extremity Deep Venous Thrombosis
NCT02945280Phase 4Terminated
- Sponsor
- Intermountain Health
- Start
- Feb 2017
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in upper extremity deep vein thrombosis (UEDVT), sponsored by Intermountain Health. Started Feb 2017; status: terminated.
02
Drugs
apixaban
03
Conditions
upper extremity deep vein thrombosis (UEDVT)
Beyond the preview
Go deeper on NCT02945280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02945280.